Status:

COMPLETED

Randomized Trial of eOncoNote

Lead Sponsor:

University of Toronto

Collaborating Sponsors:

Ontario Clinical Oncology Group (OCOG)

Ottawa Regional Cancer Centre

Conditions:

Communication Research

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Improving Cancer Care Together through eOncoNote is a pragmatic randomized trial involving a secure online eConsultation system (referred to as eOncoNote) that will allow primary care providers and ca...

Detailed Description

The overall objectives of this randomized trial are to test an intervention designed to improve coordination/continuity of care between primary care providers (PCPs) and cancer specialist providers (C...

Eligibility Criteria

Inclusion

  • Patient inclusion criteria:
  • at least 18 years of age,
  • being in one of the following three cancer continuum specific phases:
  • Diagnosis phase: patients referred to the Cancer Assessment Clinic with suspected colorectal, prostate, or lung cancer;
  • Treatment phase: patients receiving adjuvant chemotherapy for early stage breast cancer, or radical or adjuvant radiation therapy for localized prostate cancer;
  • Survivorship phase: patients referred to the Wellness Beyond Cancer Program post completion of their adjuvant therapy for either breast or colorectal cancer with the intent of being discharged for survivorship care to their own family physician;
  • no prior history of cancer in the past 5 years (those with non-melanoma skin cancer can participate).
  • Patient exclusion criteria:
  • Currently participating in another study requiring ongoing completion of patient reported outcome measures (such as quality of life measures) in order to minimize respondent burden,
  • Does not have a primary care provider,
  • Patients will be excluded if their primary care provider has another patient enrolled in the trial in order to control for contamination between randomization groups,
  • Inability to read and write in English,
  • Inability to provide informed consent, and
  • In the survivorship phase, patients who are discharged to the Wellness Beyond Cancer Program nurse practitioner (rather than their primary care providers) will be excluded.
  • Primary care providers eligibility criteria:
  • Licensed family physician or nurse practitioner,
  • Their patient has consented to be enrolled in the study, and they do not have any other patients enrolled in the study (to avoid contamination between intervention and control groups),
  • They are already registered on the Champlain BASE(TM) eConsult system prior to their patient being enrolled in the study.

Exclusion

    Key Trial Info

    Start Date :

    February 5 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 17 2021

    Estimated Enrollment :

    181 Patients enrolled

    Trial Details

    Trial ID

    NCT03333785

    Start Date

    February 5 2018

    End Date

    February 17 2021

    Last Update

    April 29 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada, K1H 8L6